Posts

Showing posts with the label CAR-T Cell Therapy

Future Prospects of Global Laboratory Proficiency Testing Market

Image
Laboratory Proficiency Testing Market  The global Laboratory Proficiency Testing Market is estimated to be valued at US$ 1.29 billion in 2023 and is expected to exhibit a CAGR of 7.3% over the forecast period 2023 - 2030, as highlighted in a new report published by Coherent Market Insights. Market Overview: Laboratory proficiency testing involves evaluating the performance of laboratories for a given scope of testing through inter-laboratory comparisons. It helps assess the quality and competence of laboratories by determining reproducibility and accuracy of test results. Proficiency testing products are used by laboratories to determine method validity and accuracy, and improve testing processes. Market Key Trends: One of the major trends in the laboratory proficiency testing market is the growing number of accredited medical laboratories. Accreditation assures compliance with ISO 15189 and ISO/IEC 17025 standards, which require participation in proficiency testing programs. Acc...

CAR-T Cell Therapy Market — A Cancer Treatment Revolution

Image
Cancer therapy, such as targeted immunotherapies, such as CAR-T cell therapies , has recently surpassed surgery, chemotherapy, and radiation. These are drugs that target cancer cells and help the patient's immune system fight the tumour. T-cells derived from a patient's blood are modified in the lab with the addition of a special protein receptor on the T-cells that attack cancer cells, known as CAR-T cell therapy . Chimeric Antigen Receptor (CAR) is a unique receptor that attaches to a specific protein on cancer cells in patients. Hundreds of millions of CAR-T cells are generated in the lab before being infused into patients. These cells bind to infected cancer cells and have the power to kill them, resulting in the cancer being cured. Immune checkpoint inhibitors, which can detect and stop cancer cells, can be used to battle cancer cells masking themselves from immune cells. The treatment of children recurrent acute lymphoblastic leukaemia, refractory non-Hodgkin lymphoma, an...

Popular posts from this blog

Future Prospects of Global Laboratory Proficiency Testing Market

Malaria Vaccines Market – Making Way for a Malaria-Free World

Global and China Catheter Market Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027